Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary End Points Article

cited authors

  • Shore, Neal D.; De Giorgi, Ugo; Tutrone, Ronald F.; Bailen, James L.; Roos, Erik P. M.; Kliment, Jan; Marx, Gavin; Karsh, Lawrence I.; Ramirez-Backhaus, Miguel; Uchio, Edward M.; Supiot, Stephane; Tang, Yiyun; Rosbrook, Brad; Haas, Gabriel P.; Rosales, Matt; Zohren, Fabian; Tarazi, Jamal; Freedland, Stephen J.

Publication Date

  • April 1, 2026

webpage

published in

category

keywords

  • enzalutamide
  • leuprolide acetate
  • metastasis
  • prostate cancer
  • recurrence

volume

  • 215

issue

  • 4